1. Home
  2. SEVN vs VYGR Comparison

SEVN vs VYGR Comparison

Compare SEVN & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seven Hills Realty Trust

SEVN

Seven Hills Realty Trust

HOLD

Current Price

$8.43

Market Cap

187.6M

Sector

Real Estate

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.48

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SEVN
VYGR
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.6M
203.6M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
SEVN
VYGR
Price
$8.43
$3.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$10.50
$16.50
AVG Volume (30 Days)
82.8K
568.1K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
13.90%
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
$29,383,000.00
$10,135,000.00
Revenue This Year
$27.75
$34.04
Revenue Next Year
$4.06
$7.92
P/E Ratio
$44.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$2.83
52 Week High
$12.85
$5.55

Technical Indicators

Market Signals
Indicator
SEVN
VYGR
Relative Strength Index (RSI) 49.73 43.51
Support Level $8.33 $3.31
Resistance Level $8.83 $4.29
Average True Range (ATR) 0.17 0.20
MACD -0.01 -0.02
Stochastic Oscillator 16.67 30.77

Price Performance

Historical Comparison
SEVN
VYGR

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: